Apathy is a disabling syndrome associated with poor functional outcomes that is common across a broad range of neurological and psychiatric conditions. Currently, there are no established therapies specifically for the condition, and safe and effective treatments are urgently needed. Advances in the understanding of motivation and goal-directed behavior in humans and animals have shed light on the cognitive and neurobiological mechanisms contributing to apathy, providing an important foundation for the development of new treatments. Here, we review the cognitive components, neural circuitry, and pharmacology of apathy and motivation, highlighting converging evidence of shared transdiagnostic mechanisms. Though no pharmacological treatments have yet been licensed, we summarize trials of existing and novel compounds to date, identifying several promising candidates for clinical use and avenues of future drug development.

中文翻译：

---

冷漠和动机：生物学基础和药物治疗

冷漠是一种与功能不良相关的致残综合征，在广泛的神经和精神疾病中很常见。目前，尚无专门针对该疾病的既定疗法，迫切需要安全有效的治疗方法。对人类和动物动机和目标导向行为的理解的进展揭示了导致冷漠的认知和神经生物学机制，为新疗法的开发提供了重要基础。在这里，我们回顾了冷漠和动机的认知成分、神经回路和药理学，强调了共同的跨诊断机制的汇聚证据。尽管尚未获得药物治疗许可，但我们总结了迄今为止对现有化合物和新型化合物的试验，确定了几种有前途的临床使用候选药物和未来药物开发的途径。